According to an exchange filing, the pharma major said the inspection took place between September 8 and September 19, 2025, ...
We continue to manufacture and supply approved products from the facility to the US market. We will work with the regulator ...
Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...
Shares of Sun Pharmaceutical Industries Ltd. are trading 2.4% lower on Thursday, December 18, after the US Food and Drug ...
Shares of Sun Pharmaceutical Industries closed 2.77% lower on Thursday (December 18, 2025) at ₹1,745.35 apiece on the BSE ...
Sun Pharmaceutical Industries Limited ( ($IN:SUNPHARMA) ) has provided an update. Sun Pharmaceutical Industries Limited announced that the US FDA ...
Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter
A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...
Outlook Business on MSN
Sun Pharma gets OAI classification from USFDA for Baska facility
Sun Pharma on Thursday said the US health regulator has classified its Baska facility in Gujarat under Official Action ...
Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.
Sun Pharma informed the stock exchanges that the board of directors of its subsidiary Sun Pharma Laboratories approved the investment proposal of ₹3,000 crore to set up a greenfield formulations ...
Sun Pharma announced Thursday morning that it is acquiring Concert Pharmaceuticals for $576 million. The Indian-based pharma company will acquire all outstanding shares of the late-stage biotech that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback